Positive study enables valuable repositioning of new antifibrotic drug candidates by a growing number of pharma companies SAN DIEGO, Oct. 17, 2024 /PRNewswire/ — MeCo Diagnostics, a venture-backed startup dedicated to unlocking a new therapeutic modality for cancer, has announced a…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.